|
시장보고서
상품코드
2054980
복합 주사제 시장 : 분자 유형별, 치료 용도별, 제품 유형별, 포장 형태별, 투여 경로별, 연령층별, 유통 채널별, 최종사용자별, 지역별Complex Injectable Market, By Molecule Type, By Therapeutic Application, By Product Type, By Packaging Type, By Route of Administration, By Age Group, By Distribution Channel, By End User, By Geography |
||||||
복합 주사제 시장은 2026년에 284억 1,000만 달러로 추정되며, 2033년까지 512억 7,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.8%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 284억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.80% | 2033년 시장 규모 예측 : | 512억 7,000만 달러 |
세계 복합 주사제 시장은 제약 업계 내에서 급속히 발전하고 있는 분야로, 특수한 제조, 취급 및 투여 절차가 필요한 첨단 약물 전달 시스템을 포괄하고 있습니다. 복합 주사제에는 리포솜, 마이크로스피어, 에멀젼, 현탁액 및 기타 첨단 제형 등 다양한 제품이 포함됩니다. 이러한 제품들은 복잡한 제조 공정과 고유한 물리화학적 특성으로 인해 쉽게 복제할 수 없습니다. 이러한 제품들은 기존의 주사제와 비교해 치료 효과 향상, 환자의 복약 순응도 개선, 그리고 표적 지향적 약물 전달 능력을 제공함으로써 최근 큰 주목을 받고 있습니다.
이 시장은 복잡한 제네릭 의약품과 혁신적인 바이오의약품을 모두 아우르며, 종양학, 면역학, 순환기학, 중추신경계 질환 등 주요 치료 분야에 기여하고 있습니다. 만성 질환 유병률 증가, 맞춤형 의료에 대한 수요 증가, 그리고 전 세계 의료비 상승이 이 시장의 눈부신 성장에 기여하고 있습니다. 또한, 몇몇 블록버스터급 복합 주사제의 특허 만료는 제네릭 제약사들에게 유리한 기회를 제공하고 있으며, 한편으로 약물 전달 시스템의 기술적 진보는 이 분야의 혁신을 지속적으로 주도하고 있어, 복합 주사제는 현대 의료 서비스 제공 시스템에서 없어서는 안 될 요소가 되었습니다.
시장 역학
세계 복합 주사제 시장은 성장을 지속적으로 뒷받침하는 몇 가지 강력한 요인에 의해 주로 견인되고 있습니다. 암, 당뇨병, 자가면역질환, 심혈관 질환 등 만성 질환의 유병률 증가는 우수한 생체이용률과 표적 전달 메커니즘을 통해 복합 주사제가 제공할 수 있는 첨단 치료 솔루션에 대한 큰 수요를 창출하고 있습니다. 수많은 블록버스터급 복합 주사제의 특허 만료는 제네릭 제약사들이 바이오시밀러나 제네릭 의약품으로 시장에 진입할 수 있는 큰 기회를 제공하며, 이를 통해 시장의 접근성을 높이고 의료 비용을 절감하고 있습니다. 나노기술 기반의 제제, 서방 메커니즘, 정밀의학 접근법 등 약물 전달 시스템의 기술적 진보가 혁신을 주도하며 새로운 치료의 가능성을 열어가고 있습니다.
세계적인 고령화 추세에 더해, 신흥 시장의 의료비 증가와 의료 인프라 확충이 시장 확대를 더욱 가속화하고 있습니다. 그러나 시장에는 대규모 임상시험이나 복잡한 승인 절차를 요구하는 엄격한 규제 요건 등 뚜렷한 제약이 존재하며, 이러한 요인들이 개발 비용과 시장 출시까지의 기간을 크게 늘리고 있습니다. 복잡한 주사제의 제조에는 고도로 정교한 공정이 필요하며, 이를 위해서는 전문적인 시설과 장비에 대한 막대한 설비 투자가 필수적이어서, 이것이 신규 진입의 장벽이 되고 있습니다. 게다가, 이러한 제품들의 기술적 복잡성은 생물학적 동등성 달성 및 품질 일관성 확보에 어려움을 초래하고 있으며, 제제 개발 및 규제 대응에 관한 전문 지식의 부족 또한 시장 진입을 제한하고 있습니다. 이러한 과제들이 있음에도 불구하고, 헬스케어의 디지털화 진전, 제약 부문이 성장하는 신흥 시장에서의 확장, 선도 기업과 제네릭 제조업체 간의 전략적 제휴, 그리고 새로운 약물 전달 기술과 맞춤형 의료 접근법에 초점을 맞춘 지속적인 연구 개발 노력을 통해 많은 기회가 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략)를 바탕으로 전 세계 복합 주사제 시장의 주요 기업 프로파일을 작성하였습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 복합 주사제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 복합 주사제 시장 : 분자 유형별, 2021년-2033년
제5장 세계의 복합 주사제 시장 : 치료 용도별, 2021년-2033년
제6장 세계의 복합 주사제 시장 : 제품 유형별, 2021년-2033년
제7장 세계의 복합 주사제 시장 : 포장 유형별, 2021년-2033년
제8장 세계의 복합 주사제 시장 : 투여 경로별, 2021년-2033년
제9장 세계의 복합 주사제 시장 : 연령층별, 2021년-2033년
제10장 세계의 복합 주사제 시장 : 유통 채널별, 2021년-2033년
제11장 세계의 복합 주사제 시장 : 최종사용자별, 2021년-2033년
제12장 세계의 복합 주사제 시장 : 지역별, 2021년-2033년
제13장 경쟁 구도
제14장 애널리스트의 제안
제15장 참고 문헌 및 조사 방법
LSHComplex Injectable Market is estimated to be valued at USD 28.41 Bn in 2026 and is expected to reach USD 51.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 28.41 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.80% | 2033 Value Projection: | USD 51.27 Bn |
The global complex injectable market represents a rapidly evolving segment of the pharmaceutical industry, encompassing sophisticated drug delivery systems that require specialized manufacturing, handling, and administration protocols. Complex injectables include a diverse range of products such as liposomes, microspheres, emulsions, suspensions, and other advanced formulations that cannot be easily replicated due to their intricate manufacturing processes and unique physicochemical properties. These products have gained significant traction in recent years as they offer enhanced therapeutic efficacy, improved patient compliance, and targeted drug delivery capabilities compared to conventional injectable formulations.
The market encompasses both branded complex generics and innovative biologics, serving critical therapeutic areas including oncology, immunology, cardiology, and central nervous system disorders. The increasing prevalence of chronic diseases, growing demand for personalized medicine, and rising healthcare expenditure globally have contributed to the substantial growth of this market. Additionally, the patent expiration of several blockbuster complex injectable drugs has created lucrative opportunities for generic manufacturers, while technological advancements in drug delivery systems continue to drive innovation in this space, making complex injectables an essential component of modern healthcare delivery systems.
Market Dynamics
The global complex injectable market is primarily driven by several compelling factors that continue to propel its growth trajectory. The increasing prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders, and cardiovascular diseases has created substantial demand for advanced therapeutic solutions that complex injectables can provide through their superior bioavailability and targeted delivery mechanisms. Patent cliffs of numerous blockbuster complex injectable drugs have opened significant opportunities for generic manufacturers to enter the market with biosimilar and generic versions, thereby expanding market accessibility and reducing healthcare costs. Technological advancements in drug delivery systems, including nanotechnology-based formulations, sustained-release mechanisms, and precision medicine approaches, are driving innovation and creating new therapeutic possibilities.
The growing aging population worldwide, coupled with rising healthcare expenditure and improved healthcare infrastructure in emerging markets, further supports market expansion. However, the market faces notable restraints including stringent regulatory requirements that demand extensive clinical trials and complex approval processes, significantly increasing development costs and time-to-market. The highly sophisticated manufacturing processes required for complex injectables necessitate substantial capital investments in specialized facilities and equipment, creating barriers for new entrants. Additionally, the technical complexity of these products poses challenges in achieving bioequivalence and ensuring consistent quality, while limited expertise in formulation development and regulatory affairs restricts market participation. Despite these challenges, opportunities abound through increasing healthcare digitalization, expansion in emerging markets with growing pharmaceutical sectors, strategic partnerships between innovator companies and generic manufacturers, and continuous research and development efforts focused on novel drug delivery technologies and personalized medicine approaches.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global complex injectable market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Pfizer Inc, Novartis AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc, Sanofi SA, GlaxoSmithKline plc, AstraZeneca PLC, Eli Lilly and Company, Amgen Inc, AbbVie Inc, Bristol Myers Squibb, Takeda Pharmaceutical Co. Ltd, Biogen Inc, and Gilead Sciences Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global complex injectable market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global complex injectable market
Market Segmentation
- Molecule Type Insights (Revenue, USD Bn, 2021 - 2033)
- Small Molecule
- Biologics-Based
- Therapeutic Application Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Metabolic Disorders
- Hematological Disorders
- Neurological Disorders
- Ophthalmology
- Dermatology
- Cardiovascular Diseases
- Others (Rare Diseases)
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Monoclonal Antibodies
- Peptides and Proteins
- Antibiotics
- Chemotherapy Agents
- Hormones
- Blood Factors
- Gene Therapy Products
- Cell Therapy Products
- Others (Oligonucleotides)
- Packaging Type Insights (Revenue, USD Bn, 2021 - 2033)
- Vials
- Prefilled Syringes
- Ampoules
- Cartridges
- Others (IV Bags)
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
- Intrathecal
- Intra-articular
- Other Parenteral Routes (Intradermal)
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Home Healthcare Settings
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc
- Novartis AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson
- Merck & Co., Inc
- Sanofi SA
- GlaxoSmithKline plc
- AstraZeneca PLC
- Eli Lilly and Company
- Amgen Inc
- AbbVie Inc
- Bristol Myers Squibb
- Takeda Pharmaceutical Co. Ltd
- Biogen Inc
- Gilead Sciences Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Complex Injectable Market, By Molecule Type
- Global Complex Injectable Market, By Therapeutic Application
- Global Complex Injectable Market, By Product Type
- Global Complex Injectable Market, By Packaging Type
- Global Complex Injectable Market, By Route of Administration
- Global Complex Injectable Market, By Age Group
- Global Complex Injectable Market, By Distribution Channel
- Global Complex Injectable Market, By End User
- Global Complex Injectable Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Complex Injectable Market, By Molecule Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biologics-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Complex Injectable Market, By Therapeutic Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hematological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Rare Diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Complex Injectable Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Peptides and Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chemotherapy Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Blood Factors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gene Therapy Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cell Therapy Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Oligonucleotides)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Complex Injectable Market, By Packaging Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prefilled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ampoules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cartridges
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (IV Bags)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Complex Injectable Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intrathecal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intra-articular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Parenteral Routes (Intradermal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Complex Injectable Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Complex Injectable Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Complex Injectable Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Complex Injectable Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Molecule Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Packaging Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biogen Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
